Concepedia

Paul Rogers

PR

Statistics

Publications

22

Citations

3.9K

H-Index

20

Active since

1990

Affiliations

La Jolla Institute for Immunology(Current)

University of California San Diego

University of Minnesota

Fate Therapeutics (United States)

University of Massachusetts Chan Medical School

Paul Rogers is an author at La Jolla Institute for Immunology specializing in immunology, life sciences, and cell biology.

Publications per year

1990–2021

22

Publications

22

OX40 Promotes Bcl-xL and Bcl-2 Expression and Is Essential for Long-Term Survival of CD4 T Cells

Paul Rogers, Jianxun Song, Irene Gramaglia et al. · Immunity · 2001 · 639 citations · Full text

, , +13

Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis

Xiaohong Zhang, Thomas Brunner, Laura Carter et al. · The Journal of Experimental Medicine · 1997 · 470 citations · Full text

, , +17

Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

Yuki Kinjo, Petr A. Illarionov, José Luis Vela et al. · Nature Immunology · 2011 · 342 citations · Full text

, , +14

Qualitative Changes Accompany Memory T Cell Generation: Faster, More Effective Responses at Lower Doses of Antigen

Paul Rogers, Caroline Dubey, Susan L. Swain · The Journal of Immunology · 2000 · 279 citations · Full text

, , +17

Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity

Zhu Huang, Robert Blum, Ryan Bjordahl et al. · Blood · 2019 · 275 citations · Full text

, , +17

1–5 of 22